{"id":3697,"date":"2016-06-13T00:00:00","date_gmt":"2016-06-13T00:00:00","guid":{"rendered":"http:\/\/pl-asapbio.local\/summary-of-the-asapbio-funders-workshop\/"},"modified":"2025-03-28T21:38:30","modified_gmt":"2025-03-28T21:38:30","slug":"summary-of-the-asapbio-funders-workshop","status":"publish","type":"post","link":"https:\/\/asapbio.org\/summary-of-the-asapbio-funders-workshop\/","title":{"rendered":"Summary of the ASAPbio Funders\u2019 Workshop"},"content":{"rendered":"

The following is a message from funding agency representatives who attended our recent Funders\u2019 Workshop<\/a>.<\/em><\/p>\n

As research funders who attended the <\/span>ASAPbio Funder\u2019s Workshop for Preprints<\/span><\/a> held at the National Institutes of Health (NIH) on May 23-24, 2016, we wish to provide a brief summary of the meeting. This follows the initial <\/span>Funder\u2019s Perspective<\/span><\/a> drawn from the <\/span>first ASAPbio Workshop<\/span><\/a> held on February 16-17, 2016, and continues our desire to be transparent while the community continues to explore the value of preprints to the biomedical research enterprise.<\/span><\/p>\n

At this workshop, the funders were presented with a summary from the first workshop and the results of a <\/span>survey<\/span><\/a> conducted by ASAPbio. This was followed by an open discussion of the scholarly and technical goals of a preprint service. The agenda then moved to a discussion of two exemplary models of shared governance of a resource in an international setting, Europe PubMedCentral (<\/span>Europe PMC<\/span><\/a>) and the Worldwide Protein Data Bank (<\/span>wwPDB<\/span><\/a>). The final context setting for the funders discussion was provided by representatives of existing and anticipated preprint services,  <\/span>ArXiv<\/span><\/a>, <\/span>bioRxiv<\/span><\/a>, <\/span>PeerJ<\/span><\/a>, <\/span>F1000 Research<\/span><\/a>, and <\/span>PLOS<\/span><\/a>. What followed was an open session with all stakeholders present and a closed session involving only the funders.<\/span><\/p>\n

The consensus of the workshop attendees reflected high enthusiasm about further development of a preprint service for the life sciences. At the end of the day, it was agreed by all in attendance that:<\/span><\/p>\n

    \n
  1.      <\/span>A preprint policy that is as homogeneous as possible across funders is desired, especially in the way that preprints are considered as part of proposal grant submission and review. A subgroup of funders will draft a concept paper addressing some of the policy issues that might arise when implementing such a preprint policy. This draft will be shared with other funders for their input.<\/span><\/li>\n
  2.      <\/span>The funders asked ASAPbio to develop a proposal describing the governance, infrastructure and standards desired for a preprint service that represents the views of the broadest number of stakeholders. The proposal should include a budget, goals, milestones and implementation timeline to bring an appropriate community defined preprint service into operation.<\/span><\/li>\n
  3.      <\/span>This letter be distributed as widely as possible to inform all stakeholders of the continued interest by funders in expanding the use of preprints by the life sciences community.<\/span><\/li>\n<\/ol>\n

    Philip Bourne, The National Institutes of Health
    \nMaryrose Franko, Health Research Alliance
    \nMichele Garfinkel, European Molecular Biology Organization
    \nJudith Glaven, Howard Hughes Medical Institute
    \nEric Green, The National Institutes of Health
    \nJosh Greenberg, The Alfred P Sloan Foundation
    \nJennifer Hansen, Bill and Melinda Gates Foundation
    \nRobert Kiley, The Wellcome Trust
    \nCecy Marden, The Wellcome Trust
    \nPaul Lasko, Canadian Institutes of Health Research
    \nMaria Leptin, European Molecular Biology Organization
    \nTony Peatfield, Medical Research Council, UK
    \nBrooke Rosenzweig, The Helmsley Trust
    \nJane Silverthorne, The National Science Foundation
    \nJohn Spiro, The Simons Foundation
    \nMichael Stebbins, The Arnold Foundation
    \nNils Stenseth, European Research Council
    \nCarly Strasser, Gordon and Betty Moore Foundation
    \nNeil Thakur, The National Institutes of Health
    \nK. VijayRaghavan, Department of Biotechnology, India<\/p>\n","protected":false},"excerpt":{"rendered":"

    The following is a message from funding agency representatives who attended our recent Funders\u2019 Workshop. As research funders who attended the ASAPbio Funder\u2019s Workshop for Preprints held at the National […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[41],"tags":[],"class_list":["post-3697","post","type-post","status-publish","format-standard","hentry","category-asapbio-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/posts\/3697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/comments?post=3697"}],"version-history":[{"count":1,"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/posts\/3697\/revisions"}],"predecessor-version":[{"id":4610,"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/posts\/3697\/revisions\/4610"}],"wp:attachment":[{"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/media?parent=3697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/categories?post=3697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asapbio.org\/wp-json\/wp\/v2\/tags?post=3697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}